Pharmaron Beijing Co., Ltd. (300759.SZ)
CNY 22.48
(-1.88%)
CNY 22.48
(-1.88%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.90 CNY | 15.38% |
| 2022 | 0.78 CNY | -16.13% |
| 2021 | 0.93 CNY | 40.91% |
| 2020 | 0.66 CNY | 78.38% |
| 2019 | 0.37 CNY | -2.63% |
| 2018 | 0.38 CNY | 46.15% |
| 2017 | 0.26 CNY | 13.04% |
| 2016 | 0.23 CNY | -39.47% |
| 2015 | 0.38 CNY | 815.66% |
| 2014 | 0.04 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 0.17 CNY | -66.0% |
| 2024 Q1 | 0.13 CNY | -50.0% |
| 2024 Q2 | 0.50 CNY | 284.62% |
| 2023 FY | - CNY | 15.38% |
| 2023 Q3 | 0.30 CNY | 20.0% |
| 2023 Q2 | 0.25 CNY | 25.0% |
| 2023 Q1 | 0.20 CNY | -13.04% |
| 2023 Q4 | 0.26 CNY | -13.33% |
| 2022 Q1 | 0.21 CNY | -73.08% |
| 2022 Q3 | 0.47 CNY | 9.3% |
| 2022 Q4 | 0.23 CNY | -51.06% |
| 2022 FY | - CNY | -16.13% |
| 2022 Q2 | 0.43 CNY | 104.76% |
| 2021 Q3 | 0.60 CNY | 50.0% |
| 2021 Q4 | 0.78 CNY | 30.0% |
| 2021 Q1 | 0.21 CNY | -57.14% |
| 2021 FY | - CNY | 40.91% |
| 2021 Q2 | 0.40 CNY | 90.48% |
| 2020 Q3 | 0.26 CNY | -45.83% |
| 2020 Q2 | 0.48 CNY | 460.09% |
| 2020 Q1 | 0.09 CNY | -74.03% |
| 2020 FY | - CNY | 78.38% |
| 2020 Q4 | 0.49 CNY | 88.46% |
| 2019 Q4 | 0.33 CNY | 94.12% |
| 2019 Q3 | 0.17 CNY | 0.0% |
| 2019 Q2 | 0.17 CNY | 198.25% |
| 2019 Q1 | 0.06 CNY | -68.33% |
| 2019 FY | - CNY | -2.63% |
| 2018 Q4 | 0.18 CNY | 50.0% |
| 2018 FY | - CNY | 46.15% |
| 2018 Q3 | 0.12 CNY | -14.29% |
| 2018 Q2 | 0.14 CNY | 203.69% |
| 2018 Q1 | 0.05 CNY | -64.54% |
| 2017 Q4 | 0.13 CNY | 0.0% |
| 2017 FY | - CNY | 13.04% |
| 2016 FY | - CNY | -39.47% |
| 2015 FY | - CNY | 815.66% |
| 2014 FY | - CNY | 0.0% |